WebApr 11, 2024 · Insights from management, analyst sentiment and the divergence from earnings call transcripts. Furthermore, CXO priorities around investments, acquisitions, R&D, human capital, evolving risk exposures and geographic concerns help in understanding key strategic developments. Competitive Benchmarking WebApr 9, 2024 · Incyte Stock Performance. Shares of INCY opened at $75.51 on Friday. The company has a market capitalization of $16.84 billion, a price-to-earnings ratio of 49.68, a price-to-earnings-growth ratio of 3.20 and a beta of 0.73. Incyte Co. has a 52-week low of $65.07 and a 52-week high of $86.29.
Incyte Q1 2024 Earnings Call Transcript - MarketBeat.com
WebFeb 7, 2024 · Incyte (INCY) 7 Feb 232024 Q4 Earnings call transcript Company Profile Participants Call transcript Due to licensing restrictions, you must log in to view earnings call transcripts. Operator Hello, and welcome to the Incyte Fourth Quarter and Full Year Financial Results Conference Call and webcast. WebFeb 7, 2024 · Revenues from our current portfolio of commercialized products grew 18% year-over-year, both in the fourth quarter and for the full year to $764 million and $2.7 … onyx bathtub for sale
New York State Teachers Retirement System Sells 15,367 Shares of Incyte …
WebApr 11, 2024 · According to analysts' consensus price target of $85.43, Incyte has a forecasted upside of 15.2% from its current price of $74.17. Amount of Analyst Coverage Incyte has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock. See Top Rated MarketRank™ Stocks Here WebFeb 7, 2024 · Q4/YE 2024 Incyte Corporation Earnings Conference Call. Feb 7, 2024 at 8:00 AM EST Click here for Webcast. Supporting Materials. Q4 2024 Financial and Corporate Update Presentation 2.9 MB. Investor Contacts. Christine Chiou. Head of Investor Relations. 302.274.4773. [email protected] ... WebApr 11, 2024 · The company has a 50 day moving average of $76.33 and a 200-day moving average of $76.86. Incyte Co. has a 1-year low of $65.07 and a 1-year high of $86.29. Gilead Sciences: Now is Not the Time to Get Sticker Shock; Incyte (NASDAQ:INCY - Get Rating) last posted its quarterly earnings data on Tuesday, February 7th. The biopharmaceutical … onyx bathroom shower ideas